CD276 and neoplasm: Although its receptor remains unidentified, B7-H3 can inhibit T-cell activation [10], promote tumor proliferation, invasion, and migration through the ERK1/2, PI3K-AKT, NF-kB, and the JAK2/STAT3 signaling pathways [9].